Panbela Therapeutics

Minnesota City, United States

Panbela Therapeutics develops small molecule pharmaceuticals for the oncology and acute care markets.

$9.0M raised

Jan 2024

Post-IPO Equity

Biotechnology Health Care Oncology Pharmaceutical

Top Investors

Florida Institute for the Commercialization of Florida Technology

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Panbela Therapeutics

How much funding has Panbela Therapeutics raised?

Panbela Therapeutics has raised $9.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in January 2024.

Who are Panbela Therapeutics's investors?

Panbela Therapeutics's investors include Florida Institute for the Commercialization of Florida Technology.

Where is Panbela Therapeutics headquartered?

Panbela Therapeutics is headquartered in Minnesota City, United States.

What does Panbela Therapeutics do?

Panbela Therapeutics develops small molecule pharmaceuticals for the oncology and acute care markets.

What stage is Panbela Therapeutics at?

Panbela Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 29, 2024.

MLA

"Panbela Therapeutics — Funding & Investors." VCBacked, January 29, 2024, https://www.vcbacked.co/company/panbela-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2024). Panbela Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/panbela-therapeutics

Wikipedia (cite web)

{{cite web |title=Panbela Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/panbela-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 29, 2024.